Aragen Bioscience

Helping you develop
biologics faster and easier
for patients in need

Deep knowledge of
pre-clinical technologies
and methods

Transparency throughout
development

HomeMichael Biros2019-04-17T22:59:59+00:00

ANTIBODY DISCOVERY

Experts in antigen design and hybridoma development.

PROTEIN SCIENCE

In-depth experience from gene synthesis and subcloning to protein expression and purification.

EFFICACY TESTING

Proven track record for a broad range of in vitro and in vivo models of disease.

CELL LINE DEVELOPMENT

Short timelines and high titers at every development stage with RapTr^™ CLD services.

Webinar: High-Throughput Developability Assessment of Therapeutic Antibody Candidates in Discovery Stage

Relive our June 20th webinar! Instant Replay

Events

BIO Korea International Conference

April 17-19
Seoul, South Korea

Learn how we can accelerate your preclinical research projects

Client News

Proclara Biosciences Presents New Preclinical Data Supporting the Development of NPT189

Lung Therapeutics Announces Series B Funding

Testimonial

…a solid performer for my company’s animal studies…
Elisabeth Gardiner, PhD Chief Scientific Officer Meditope Biosciences, Inc.

Press Releases

Aragen Bioscience Expands RapTr Cell Line Development Services

11.10.2017
Aragen Bioscience Announces AAALAC Accreditation

06.20.2017
RapTr Cell Line Development Services Introduced